Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma

✍ Scribed by Jessica McCready; William C. Broaddus; Virginia Sykes; Helen L. Fillmore

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: French
• Weight: 199 KB
• Volume: 117
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.21207

✦ Synopsis

Abstract

A key feature in the malignant behavior of glioblastoma is the tendency to invade host brain tissue surrounding the primary tumor site. Several members of the matrix metalloproteinase family are thought to contribute to this invasive capacity. A single nucleotide polymorphism has been described in the matrix metalloproteinase‐1 (MMP‐1) promoter that consists of either the presence or absence of a guanine nucleotide at position −1607. The presence of the guanine base creates a functional binding site for members of the ETS family of transcription factors and has been shown to increase MMP‐1 transcription. The purpose of our study was to characterize this polymorphism in human glioblastoma. Promoter genotyping was performed on brain tumor tissue obtained from 81 patients and compared to 57 healthy individuals. The 2G/2G genotype is more prevalent in glioblastoma tissue compared to healthy individuals (p = 0.01). mRNA and protein expression were measured in a subset of brain tumor and normal brain tissue samples. MMP‐1 protein levels are significantly higher in glioblastoma tissue compared to normal brain (p = 0.001). Electromobility shift assays and promoter assays were performed to assess binding capability and transcriptional activity, respectively. Proteins present in glioma cell lines can specifically bind the 2G promoter probe. MMP‐1 transcription is significantly higher in cells transfected with the 2G promoter when compared to cells transfected with the 1G promoter (p<0.02). This polymorphism may provide a mechanism for increased expression of MMP‐1 in malignant gliomas via elevation of MMP‐1 mRNA transcription and may underlie the invasive phenotype. © 2005 Wiley‐Liss, Inc.